Amy Butewicz
About Amy L. Butewicz
Independent Director at UMH since 2020; age 41 as of the 2025 proxy record date. PharmD (summa cum laude), Rutgers Ernest Mario School of Pharmacy; professional background in real estate (Keller Williams Princeton Real Estate) and prior supervisory pharmacist role; active in local municipal councils and Rutgers Equine Science Center advisory board. Labeled “Independent Director” in UMH proxies; attended 100% of Board and committee meetings in the most recent year disclosed .
Past Roles
| Organization | Role/Title | Tenure | Committees/Impact |
|---|---|---|---|
| IPPC Pharmacy (Monmouth County, NJ) | Supervising Infusion Pharmacist | 2009–2017 | Healthcare operations experience cited in director bio . |
| UMH Properties, Inc. | Independent Director (Class I) | Appointed Jan 15, 2020; serving since 2020 | Appointed by Board expansion; no related-party ties at appointment . |
External Roles
| Organization | Role/Title | Tenure | Committees/Impact |
|---|---|---|---|
| Keller Williams Princeton Real Estate | Realtor (specializing in equestrian/farm/land) | 2016–present | Real estate development/sales and municipal engagement cited as Board-relevant . |
| Millstone Twp. Agricultural Advisory Council | Council Member | 2020–present | Community and land-use perspective . |
| Millstone Twp. Open Space & Farmland Preservation Council | Council Member | 2019–present | Land preservation policy exposure . |
| Rutgers University Equine Science Center | Advisory Board Co‑Chair | 2017–present | Non-profit/academic governance role . |
Board Governance
- Independence and attendance: Identified as Independent Director; 100% attendance at Board and committee meetings in the latest year disclosed .
- Committee assignments (current/most recent):
- Nominating & Corporate Responsibility Committee – Member (2024–2025) .
- Audit Committee Cybersecurity Subcommittee – Member (Chairperson is Mitchell) .
- Nominating & Corporate Responsibility Committee ESG/Sustainability Subcommittee – Member (Chairperson is Pruitt‑Marriott) .
- Not listed on Audit, Compensation, or Retirement Plan Committees in 2025 .
- Governance structure updates: In Sept. 2023, the Board renamed Nominating & Corporate Governance to Nominating & Corporate Responsibility and created an ESG Subcommittee; Butewicz appointed a member of the ESG Subcommittee .
Fixed Compensation
| Year | Cash Fees (Board + Committee) | Equity – Unrestricted Stock (grant) | Notes |
|---|---|---|---|
| 2022 | $50,000 cash retainer; $2,500 committee fees = $52,500 total cash | $49,998 (2,388 shares) | Meeting fees eliminated; standardized committee retainers instituted . |
| 2023 | $55,000 cash retainer; $7,564 committee member retainer = $62,564 total cash | $55,007 (3,594 shares) | Presiding Director cash premium separate (not applicable to her) . |
| 2024 | $72,600 fees earned/paid in cash | $60,497 (3,676 shares) | Cash increase reflects committee workloads/retainers mix . |
- Pension/Deferred comp: Company discloses no pension or nonqualified deferred compensation plans for directors (except limited legacy noted for E.W. Landy) .
Performance Compensation
| Element | Grant Details | Vesting/Terms | Performance Metrics |
|---|---|---|---|
| Stock Options (2023) | 10,000 options (grant date: Mar 21, 2023; fair value $31,000) | Time-based vesting: 20% per year over 5 years | No explicit performance metrics disclosed for director equity; awards are time-based . |
| Stock Options (2024) | 11,000 options (grant date: Jan 10, 2024; fair value $29,590) | Time-based vesting: 20% per year over 5 years; aggregate 21,000 options outstanding unexercised as of 12/31/2024 | No explicit performance metrics disclosed; time-based . |
Director Compensation (Totals)
| Year | Cash Fees | Stock Awards | Option Awards | Total |
|---|---|---|---|---|
| 2022 | $52,500 | $49,998 | — | $102,498 |
| 2023 | $62,564 | $55,007 | $31,000 | $148,571 |
| 2024 | $72,600 | $60,497 | $29,590 | $162,687 |
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None disclosed in UMH proxies/filings for Butewicz . |
| Committee interlocks/conflicts | Not indicated; at 2023 governance update, she joined ESG Subcommittee; no related-party interlocks disclosed for her . |
Expertise & Qualifications
- Real estate development/sales and municipal engagement experience cited as primary reasons for Board service; licensed realtor in NJ .
- Doctor of Pharmacy (summa cum laude), Rutgers Ernest Mario School of Pharmacy .
- Community/academic leadership roles (Millstone Township councils; Rutgers Equine Science Center co‑chair) .
Equity Ownership
| As-of Date (Proxy) | Total Beneficial Ownership (shares) | % of Shares Outstanding |
|---|---|---|
| Mar 27, 2020 (2020 DEF 14A) | 1,016 | <1% |
| Mar 26, 2021 (2021 DEF 14A) | 2,583 | <1% |
| Mar 8, 2024 (2024 DEF 14A) | 11,403 | <1% |
- Initial Form 3 (Jan 2020) reported 0 shares at appointment .
- Pledging/hedging: No pledging or hedging by Butewicz is disclosed in the cited sections; no Item 404 related-person transactions at appointment .
Insider Trades
| Date | Form | Security | Reported Holdings/Action |
|---|---|---|---|
| Jan 27, 2020 | Form 3 | UMH common | Initial statement; 0 shares beneficially owned at appointment . |
Governance Assessment
- Strengths: Independent director with 100% attendance; active on governance-related committees (Nominating & Corporate Responsibility) and ESG/Cybersecurity subcommittees; no related-party transactions or family relationships disclosed at appointment; ongoing service aligns with community and real estate experience .
- Alignment: Growing personal share ownership over time (1,016 → 2,583 → 11,403) suggests increasing alignment, though ownership remains <1% of outstanding shares as is typical for directors .
- Considerations: UMH compensates directors with unrestricted stock and time-vested stock options (10,000 in 2023; 11,000 in 2024), without disclosed performance conditions; investors may monitor how option usage for directors evolves over time .
- Red flags observed in filings: None specific to Butewicz—no attendance issues, no Item 404 related-party transactions at appointment; independence affirmed in proxies .